Unpacking adverse events and associations post COVID-19 vaccination: a deep dive into vaccine adverse event reporting system data

References

• World Health Organization. WHO Coronavirus (COVID-19) Dashboard. [cited 2023 Jul 30]; https://covid19.who.int/
   Google Scholar
• Acosta-Coley I, Cervantes-Ceballos L, Tejeda-Benítez L, et al. Vaccines platforms and COVID-19: what you need to know. Trop Dis Travel Med Vaccines. 2022;8(1):20. doi: 10.1186/s40794-022-00176-4
   PubMedGoogle Scholar
• Li Y, Li J, He J, et al. AE-GPT: using large language models to extract adverse events from surveillance reports-a use case with influenza vaccine adverse events. arXiv.org. Sep 2023. doi: 10.48550/arXiv.2309.16150
   Google Scholar
• Hause AM, Baggs J, Marquez P, et al. Safety monitoring of COVID-19 vaccine booster doses among adults—United States, September 22, 2021–February 6, 2022. Morbidity Mortality Weekly Rep. 2022;71(7):249. doi: 10.15585/mmwr.mm7107e1
   PubMed Web of Science ®Google Scholar
• Nohynek H, Wilder-Smith A. Does the world still need new covid-19 vaccines? N Engl J Med. 2022;386(22):2140–2142. doi: 10.1056/NEJMe2204695
   PubMed Web of Science ®Google Scholar
• Chen RT, Rastogi S, Mullen J, et al. The vaccine adverse event reporting system (VAERS). Vaccine. 1994 May;12(6):542–550. doi: 10.1016/0264-410X(94)90315-8
   PubMed Web of Science ®Google Scholar
• About VAERS. Vaccine Adverse Event Reporting System. [cited 2023 Apr 12]. [ Online]. Online https://vaers.hhs.gov/about.html
   Google Scholar
• CDC WONDER. Wide-ranging Online Data for Epidemiologic Research (CDC WONDER). [cited 2023 Apr 12]. [ Online]. Online https://wonder.cdc.gov/
   Google Scholar
• Minka SO, Minka FH. A tabulated summary of the evidence on humoral and cellular responses to the SARS-CoV-2 Omicron VOC, as well as vaccine efficacy against this variant. Immunol Lett. 2022Mar;243:38–43. doi: 10.1016/j.imlet.2022.02.002
   PubMed Web of Science ®Google Scholar
• Dighriri IM, Alhusayni KM, Mobarki AY, et al. Pfizer-BioNTech COVID-19 vaccine (BNT162b2) side effects: a systematic review. Cureus. 2022 Mar. doi: 10.7759/cureus.23526.
   Web of Science ®Google Scholar
• Anand P, Stahel VP. The safety of Covid-19 mRNA vaccines: a review. Patient Saf Surg. 2021 May;15(1):20. doi: 10.1186/s13037-021-00291-9
   PubMed Web of Science ®Google Scholar
• Oliver SE, Gargano <, Scobie <, et al. The advisory committee on immunization practices’ interim recommendation for use of Janssen COVID-19 vaccine — United States, February 2021. MMWR Morb Mortal Wkly Rep. 2021 Mar;70(9):329–332.doi: 10.15585/mmwr.mm7009e4.
   PubMed Web of Science ®Google Scholar
• Food and Drug Administration. Janssen COVID-19 vaccine emergency use authorization. 2021. [cited 2023 Apr 12]. [ Online]. Online. https://www.fda.gov/emergency-preparedness-and-response/coronavirus-disease-2019-covid-19/Janssen-covid-19-vaccine
   Google Scholar
• Shinde V, Bhikha S, Hoosain Z, et al. Efficacy of NVX-CoV2373 Covid-19 Vaccine against the B.1.351 Variant. N Engl J Med. 2021 May;384(20):1899–1909.doi: 10.1056/NEJMoa2103055
   PubMed Web of Science ®Google Scholar
• Li M, Yuan J, Lv G, et al. Myocarditis and pericarditis following COVID-19 vaccination: inequalities in age and vaccine types. J Pers Med. 2021 Oct;11(11):1106. doi: 10.3390/jpm11111106
   PubMed Web of Science ®Google Scholar
• Frontera JA, Tamborska AA, Doheim MF, et al. Neurological events reported after covid-19 vaccines: an analysis of VAERS. Ann Neurol. 2022 Mar;91(6):756–771.doi: 10.1002/ana.26339
   PubMed Web of Science ®Google Scholar
• Gringeri M, Battini V, Cammarata G, et al. Herpes zoster and simplex reactivation following COVID-19 vaccination: new insights from a vaccine adverse event reporting system (VAERS) database analysis. Expert Rev Vaccines. 2022 May;21(5):675–684.doi: 10.1080/14760584.2022.2044799
   PubMed Web of Science ®Google Scholar
• Lv G, Yuan J, Xiong X, et al. Mortality rate and characteristics of deaths following COVID-19 vaccination. Front Med. 2021;8:670370. 10.3389/fmed.2021.670370
   Web of Science ®Google Scholar
• Brown EG, Wood L, Wood S. The medical dictionary for regulatory activities (MedDRA). Drug Saf. 1999 Feb;20(2):109–117. doi: 10.2165/00002018-199920020-00002.
   PubMed Web of Science ®Google Scholar
• International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH). MedDRA version 24.1: what’s new. 2021. [cited 2023 Apr 14]. [ Online]. Online. https://admin.meddra.org/sites/default/files/guidance/file/000636_whatsnew_24_1.pdf
   Google Scholar
• “Human disease ontology < ontology lookup service < embl-ebi.” [cited 2023 Jul 31]. [Online]. Available from: https://www.ebi.ac.uk/ols/ontologies/doid
   Google Scholar
• Li Y, Li J, Dang Y, et al. Temporal and spatial analysis of COVID-19 vaccines using reports from vaccine adverse event reporting system. JMIR Preprints. 2023. https://preprints.jmir.org/preprint/51007
   Google Scholar
• Singleton JA, Lloyd JC, Mootrey GT, et al. An overview of the vaccine adverse event reporting system (VAERS) as a surveillance system. Vaccine. 1999 Jul;17(22):2908–2917. doi: 10.1016/S0264-410X(99)00132-2
   PubMed Web of Science ®Google Scholar
• Mozzicato P. MedDRA. Pharm med. 2009 Apr;23(2):65–75. doi: 10.1007/BF03256752
   Google Scholar
• MedDRA Maintenance and Support Services Organization (MSSO). Introductory guide MedDRA version 25.1. Sep. 2022.
   Google Scholar
• “Stata statistical software: release 17,” 2021.
   Google Scholar
• R Core Team, R: a Language and Environment for Statistical Computing. Vienna Austria: R Foundation for Statistical Computing [Online]. [cited Jul 312021]. [Online] https://www.R-project.org/
   Google Scholar
• Cohen AC. Estimating the parameter in a conditional poisson distribution. Biometrics. 1960;16(2):203–211. doi: 10.2307/2527552
   Web of Science ®Google Scholar
• Jr DWH, Lemeshow S, Sturdivant RX. Applied logistic regression. Newark: John Wiley & Sons; 2013.
   Google Scholar
• Spearman C. The proof and measurement of association between two things. Am J Psychol. 1904;15(1):72–101. doi: 10.2307/1412159
   Google Scholar
• CDC. What to expect after getting a COVID-19 vaccine. Centers for Disease Control and Prevention. cited 2023 Apr 21. [ Online]. Available from: https://www.cdc.gov/coronavirus/2019-ncov/vaccines/expect/after.html
   Google Scholar
• CDC. COVID-19 vaccines and severe allergic reactions. Centers for Disease Control and Prevention. cited 2023 Apr 21. [ Online]. Available from: https://www.cdc.gov/coronavirus/2019-ncov/vaccines/safety/allergic-reaction.html
   Google Scholar
• CDC. COVID-19 vaccination. Centers for Disease Control and Prevention. [cited 2023 Apr 21]. [Online]. [Online] https://www.cdc.gov/coronavirus/2019-ncov/vaccines/index.html
   Google Scholar
• Paterson RW, Brown RL, Benjamin L, et al. The emerging spectrum of COVID-19 neurology: clinical, radiological and laboratory findings. Brain. 2020 Jul;143(10):3104–3120. doi: 10.1093/brain/awaa240
   PubMed Web of Science ®Google Scholar
• Blumenthal KG, Ryan EE, Li Y, et al. The impact of a reported penicillin allergy on surgical site infection risk. Clin Infect Dis. 2018 Jan;66(3):329–336. doi: 10.1093/cid/cix794
   PubMed Web of Science ®Google Scholar
• Sarti L, Lezmi G, Mori F, et al. Diagnosis and management of hypersensitivity reactions to vaccines. Expert Rev Clin Immunol. 2020 Sep;16(9):883–896. doi: 10.1080/1744666X.2020.1814745
   PubMed Web of Science ®Google Scholar
• Davenport J, Gomez R, Smith D. Latex content in adult vaccines. Mil Med. 2020 Mar;185(3–4):354–355. doi: 10.1093/milmed/usz376
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. VAERS | vaccine Safety | CDC. [Online]. [Online] https://www.cdc.gov/vaccinesafety/ensuringsafety/monitoring/vaers/index.html
   Google Scholar